Medical Devices & Surgical Robotics
Medical Devices & Surgical Robotics covers companies that design, manufacture, and support instruments, implants, imaging systems, monitoring devices, and robotic platforms used in hospitals and outpatient clinics. Capital flows to this theme because aging populations and rising chronic disease increase procedure demand while advances in sensors, miniaturization, and robotics change clinical practice and create recurring consumable revenue.
13 of 42 stocks are in a Stage 2 uptrend.
Stocks in this theme
| Ticker | Price | 1M | 3M | 1Y | Stage | Trend | vs 52w high |
|---|---|---|---|---|---|---|---|
| ATRCAtriCure, Inc. | $56.2 | +16.2% | +89.0% | +61.2% | Stage 2 (extended) | 6/7 | -7.52% |
| PLSEPulse Biosciences, Inc. | $49.92 | -0.8% | +76.2% | +180.4% | Stage 2 (extended) | 7/7 | -9.57% |
| HAEHaemonetics Corp | $105.3 | +2.2% | +40.7% | +118.8% | Stage 2 (extended) | 7/7 | -3.22% |
| ITGRInteger Holdings Corp | $126.35 | +0.9% | +33.6% | +24.9% | Stage 1 | 7/7 | -0.12% |
| DXCMDexcom Inc | $86.29 | -5.2% | +25.3% | +28.6% | Stage 2 (continuation) | 7/7 | -6.55% |
| MMSIMerit Medical Systems Inc | $86.23 | -4.9% | +24.2% | +6.6% | Stage 1 | 6/7 | -7.46% |
| TMDXTransMedics Group, Inc. | $83.45 | -1.7% | +23.0% | -25.9% | Stage 4 | 1/7 | -44.52% |
| GKOSGLAUKOS Corp | $164.19 | -8.6% | +19.4% | +101.5% | Stage 2 (continuation) | 7/7 | -13.38% |
| BDXBecton Dickinson & Co | $179 | -4.8% | +17.1% | +23.7% | Stage 1 | 5/7 | -6.77% |
| BFLYButterfly Network, Inc. | $8.96 | +13.6% | +13.0% | +357.1% | Stage 2 (extended) | 7/7 | -9.77% |
| SOLVSolventum Corp | $88.15 | -3.2% | +12.5% | +22.1% | Stage 2 (continuation) | 6/7 | -4.64% |
| BAXBaxter International Inc | $24 | -7.7% | +10.7% | +7.2% | Stage 2 (continuation) | 7/7 | -15.34% |
| UFPTUfp Technologies Inc | $296.82 | -0.4% | +10.5% | +48.9% | Stage 2 (continuation) | 6/7 | -11.35% |
| MDTMedtronic plc | $86.29 | -4.8% | +8.9% | -8.2% | Stage 3 | 3/7 | -18.09% |
| ICUIIcu Medical Inc/De | $160.51 | -7.2% | +8.1% | +35.1% | Stage 1 | 6/7 | -14.28% |
| ABTAbbott Laboratories | $98.83 | -10.4% | +7.2% | -26.0% | Stage 3 | 1/7 | -26.57% |
| ZBHZimmer Biomet Holdings, Inc. | $88.83 | -11.2% | +5.5% | -9.6% | Stage 1 | 4/7 | -14.57% |
| BLCOBausch & Lomb Corp | $17 | -2.8% | +2.7% | +13.6% | Stage 1 | 5/7 | -8.6% |
| BSXBoston Scientific Corp | $43.65 | -6.8% | +2.3% | -55.5% | Stage 4 | 0/7 | -58.42% |
| WSTWest Pharmaceutical Services Inc | $370.76 | +8.7% | +1.6% | +42.4% | Stage 1 | 7/7 | -1.56% |
| NVCRNovoCure Ltd | $15.95 | -9.6% | +1.1% | +23.4% | Stage 2 (continuation) | 7/7 | -20.21% |
| ISRGIntuitive Surgical Inc | $406.63 | +7.9% | +1.1% | -7.4% | Stage 4 | 0/7 | -31.41% |
| PENPenumbra Inc | $318.34 | -1.5% | +0.8% | +25.6% | Stage 3 | 3/7 | -11.42% |
| GEHCGE HealthCare Technologies Inc. | $65.37 | -8.2% | +0.8% | -10.6% | Stage 4 | 0/7 | -25.85% |
| STESTERIS plc | $210.01 | -9.7% | -1.1% | -15.7% | Stage 4 | 1/7 | -21.83% |
| GMEDGlobus Medical Inc | $74.9 | -8.0% | -1.4% | +32.8% | Stage 4 | 2/7 | -22.64% |
| ALCAlcon Inc | $64.75 | -10.1% | -3.1% | -12.6% | Stage 4 | 0/7 | -25.73% |
| ATRAptargroup, Inc. | $121.16 | -8.0% | -3.3% | -8.4% | Stage 1 | 3/7 | -16.85% |
| TFXTeleflex Inc | $125.04 | -12.0% | -3.6% | +3.6% | Stage 1 | 5/7 | -11.97% |
| AXGNAxogen, Inc. | $41.92 | -17.4% | -4.8% | +142.9% | Stage 2 (continuation) | 7/7 | -18.96% |
| EWEdwards Lifesciences Corp | $86.32 | -4.9% | -6.2% | +11.8% | Stage 2 (continuation) | 6/7 | -9.31% |
| SNNSmith & Nephew PLC | $26.96 | -6.3% | -6.2% | -24.1% | Stage 4 | 0/7 | -27.47% |
| LIVNLivaNova PLC | $76.5 | -4.2% | -7.3% | +46.2% | Stage 2 (continuation) | 7/7 | -10.34% |
| IRTCiRhythm Holdings, Inc. | $113.66 | -4.4% | -8.7% | -32.9% | Stage 4 | 0/7 | -39.94% |
| PHGKoninklijke Philips NV | $24.43 | -8.6% | -10.2% | -8.9% | Stage 4 | 0/7 | -25.77% |
| SYKStryker Corp | $275.39 | -14.9% | -12.1% | -25.6% | Stage 4 | 0/7 | -29.09% |
| NVSTEnvista Holdings Corp | $23.47 | -13.5% | -13.6% | +16.0% | Stage 1 | 4/7 | -22.44% |
| XRAYDENTSPLY SIRONA Inc. | $8.86 | -20.7% | -16.5% | -29.1% | Stage 4 | 0/7 | -39.65% |
| PODDInsulet Corp | $130.47 | -12.2% | -18.4% | -58.0% | Stage 4 | 0/7 | -62.33% |
| ALGNAlign Technology Inc | $145.35 | -9.0% | -19.9% | +15.0% | Stage 1 | 1/7 | -26.41% |
| COOCooper Companies, Inc. | $56.53 | -19.4% | -21.4% | -16.5% | Stage 4 | 0/7 | -32.96% |
| ESTAEstablishment Labs Holdings Inc. | $64.17 | -7.4% | -25.2% | +64.1% | Stage 1 | 4/7 | -32.91% |
Deep dive
The theme groups hardware-focused medical technology firms spanning diagnostic imaging, patient monitoring, implantable devices, minimally invasive surgical tools, and robotic-assisted surgery. Offerings range from capital equipment such as operating-room robots and imaging scanners to single-use disposables and components used in procedures. The cross-section of platform providers, device specialists, and component suppliers reflects the broad set of instruments and consumables that support modern care pathways.
Demand for these products has three linked drivers. Demographic shifts and higher prevalence of chronic conditions raise baseline procedure volumes. Clinical preference moves toward less invasive procedures and more outpatient care, which increases demand for specialized devices and point-of-care diagnostics. Technological advances in sensors, real-time data, and robotics change clinical workflows and create new use cases that attract investment and hospital capital spending.
The value chain splits into distinct roles. Large diversified medical technology firms such as Medtronic, Abbott, Baxter, GE HealthCare, and Philips supply platform systems and integrated capital equipment. Surgical-robotics and implant leaders such as Intuitive Surgical, Stryker, Zimmer Biomet, and Smith & Nephew provide procedure-focused systems and implants. Imaging and point-of-care ultrasound companies such as Butterfly Network and GE HealthCare focus on front-line diagnostics. Monitoring and chronic-disease management companies such as Dexcom and Insulet provide sensors and delivery systems. Interventional and vascular device makers such as Boston Scientific, Edwards Lifesciences, Penumbra, and Glaukos supply catheters, stents, and other therapeutic tools. Component and packaging specialists such as West Pharmaceutical Services, Integer Holdings, UFP Technologies, and Aptar supply drug-delivery components, packaging, and precision parts. Additional niches include blood-management and perfusion systems, organ-preservation devices, and tissue-repair technologies.
Continued capital interest depends on several factors. Clinical evidence and regulatory approvals determine adoption rates and payor reimbursement levels. Hospital capital budgets and procedure volumes affect device purchasing cycles. Supply-chain resilience and manufacturing scale influence margins and availability of products. Competitive innovation, pricing pressure, and patent expirations shape market share over time. Finally, the balance between one-time capital sales and recurring consumables or software-based services determines revenue stability for different companies within the theme.